Zacks Research Issues Positive Forecast for Integer Earnings

Integer Holdings Co. (NYSE:ITGR) – Zacks Research boosted their FY2024 earnings estimates for shares of Integer in a research note issued to investors on Thursday, November 14th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings of $5.32 per share for the year, up from their prior forecast of $5.28. The consensus estimate for Integer’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Integer’s Q4 2024 earnings at $1.45 EPS, Q1 2025 earnings at $1.30 EPS, Q2 2025 earnings at $1.45 EPS, Q4 2025 earnings at $1.69 EPS, FY2025 earnings at $5.99 EPS, Q1 2026 earnings at $1.63 EPS and Q2 2026 earnings at $1.57 EPS.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. During the same quarter last year, the business posted $1.27 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis.

Other research analysts have also issued reports about the stock. Citigroup lifted their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Truist Financial dropped their price target on shares of Integer from $150.00 to $147.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Piper Sandler reissued an “overweight” rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a research report on Friday, October 25th. KeyCorp boosted their target price on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. Finally, Benchmark upped their target price on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Integer has an average rating of “Moderate Buy” and an average target price of $139.75.

Integer Stock Performance

NYSE ITGR opened at $134.55 on Monday. The business’s 50 day moving average price is $129.20 and its 200-day moving average price is $122.75. Integer has a fifty-two week low of $84.75 and a fifty-two week high of $140.91. The company has a market cap of $4.51 billion, a P/E ratio of 41.10, a P/E/G ratio of 1.91 and a beta of 1.09. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Hedge Funds Weigh In On Integer

A number of institutional investors have recently modified their holdings of the stock. ProShare Advisors LLC grew its position in shares of Integer by 7.4% during the 1st quarter. ProShare Advisors LLC now owns 6,698 shares of the medical equipment provider’s stock worth $782,000 after buying an additional 461 shares in the last quarter. State Board of Administration of Florida Retirement System grew its holdings in Integer by 12.9% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 10,705 shares of the medical equipment provider’s stock worth $1,249,000 after acquiring an additional 1,220 shares in the last quarter. Vanguard Group Inc. increased its position in Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock valued at $446,428,000 after purchasing an additional 23,382 shares during the period. UniSuper Management Pty Ltd bought a new stake in shares of Integer in the 1st quarter valued at about $976,000. Finally, CANADA LIFE ASSURANCE Co raised its holdings in shares of Integer by 4.0% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 35,068 shares of the medical equipment provider’s stock valued at $4,091,000 after purchasing an additional 1,361 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.